Picture of Genetic Signatures logo

GSS Genetic Signatures Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Annual cashflow statement for Genetic Signatures, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.1680.1290.3260.1260.565
Other Operating Cash Flow
Cash from Operating Activities-2.27-9.494.29.81-12.5
Capital Expenditures-0.611-2.35-4.98-2.99-8.09
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Cash from Investing Activities-0.611-2.35-4.98-2.99-8.09
Financing Cash Flow Items-0.006-1.89-0.012-0.009-0.001
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.2536.7-0.19-0.101-0.023
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.6424.9-1.056.78-20.5